Souhaitez-vous accéder aux communiqués récents ?

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Transposon Therapeutics, a biotechnology company developing therapies for the treatment of neurodegenerative and aging-related diseases, today announced...

Oxford Healthspan announces that its longevity supplement Primeadine® GF has been named a 2026 NEXTY Awards Finalist.

PAI-1 Inhibitor (MDI-2517) demonstrates good safety and tolerability profile, with Phase 2 proof-of-concept trial planned for 2026 in patients with metabolic and fibrotic diseaseCarmel Nanthakumar,...

A Media Snippet accompanying this announcement is available by clicking on this link. ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Countdown For A Cure (CFAC) hosted its third annual Evening of...

New York, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...

Nucleus Preview is a new preconception test for couples that combines rare and chronic disease screening with trait modeling for the first time ever.

Serotonin Anti-Aging Centers signs five-location Dallas development deal, expanding physician-led longevity and wellness across North Texas.

Jennings-Brown will drive AI and technology strategy and lead the development of capabilities enabling discovery of therapeutics targeting fundamental aging mechanisms Offices in Abu Dhabi's premier...

Serotonin Centers opens its first Illinois location at Block 59 in Naperville, bringing physician-led longevity and aesthetic care to Chicagoland.

The Precision Health and Longevity Summit hosted by DIL Walk Foundation recognizes that aging is not a regional issue, but a global demographic shift.